ConductScience.org, home

Paper36720642

Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.

Largent EA and 5 others. Neurology, 2023. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Papers, record 36720642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36720642

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.
PubMed
Journal
Neurology
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
6.99
iCite
Revised in PubMed
2024-05-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Largent EAEmily Ahttps://orcid.org/0000-0002-7536-5077
2Grill JDJoshua Dhttps://orcid.org/0000-0002-4215-7589
3O'Brien KKyra
4Wolk DDavid
5Harkins KKristin
6Karlawish JJasonhttps://orcid.org/0000-0002-6880-2865

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cognitive DysfunctionMajor topic
Humans
Amyloid beta-Peptides
Biomarkers
Educational Status
tau Proteins

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 AG064123NIA NIH HHSUnited StatesK01AG064123PubMed and NIHNIH RePORTER
P30 AG072979NIA NIH HHSUnited StatesP30AG072979PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36792374Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers.https://conductscience.org/library/papers/36792374

Source PubMed

Download CSV of comments and corrections

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129197423Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.Alzheimers Res Ther2017https://conductscience.org/library/papers/29197423PubMed
230681701The Rise of Pseudomedicine for Dementia and Brain Health.JAMA2019https://conductscience.org/library/papers/30681701PubMed
326167204Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues.Neurodegener Dis Manag2013https://conductscience.org/library/papers/26167204PubMed
425984909Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants.Alzheimer Dis Assoc Disord2015https://conductscience.org/library/papers/25984909PubMed
523098912Current knowledge and future directions about the disclosure of dementia: a systematic review of the first decade of the 21st century.Alzheimers Dement2013https://conductscience.org/library/papers/23098912PubMed
629059270Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.JAMA Neurol2018https://conductscience.org/library/papers/29059270PubMed
710964998SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer.Oncologist2000https://conductscience.org/library/papers/10964998PubMed
832734458Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis.Eur J Nucl Med Mol Imaging2021https://conductscience.org/library/papers/32734458PubMed
920094021Seeking assent and respecting dissent in dementia research.Am J Geriatr Psychiatry2010https://conductscience.org/library/papers/20094021PubMed
1034040780'That would be dreadful': The ethical, legal, and social challenges of sharing your Alzheimer's disease biomarker and genetic testing results with others.J Law Biosci2021https://conductscience.org/library/papers/34040780PubMed
1130261910Study partners: essential collaborators in discovering treatments for Alzheimer's disease.Alzheimers Res Ther2018https://conductscience.org/library/papers/30261910PubMed
1230938796Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.JAMA2019https://conductscience.org/library/papers/30938796PubMed
1329653606NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement2018https://conductscience.org/library/papers/29653606PubMed
1433393982The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests.JAMA Neurol2021https://conductscience.org/library/papers/33393982PubMed
1530147000The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers.J Law Med Ethics2018https://conductscience.org/library/papers/30147000PubMed
1632777010Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment.JAMA Neurol2020https://conductscience.org/library/papers/32777010PubMed
1727060950Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.J Alzheimers Dis2016https://conductscience.org/library/papers/27060950PubMed
1825022536The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations.Alzheimers Dement2015https://conductscience.org/library/papers/25022536PubMed
1922437338Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.J Neuropathol Exp Neurol2012https://conductscience.org/library/papers/22437338PubMed
2010974954Truth-telling and the diagnosis of dementia.Br J Psychiatry2000https://conductscience.org/library/papers/10974954PubMed

See all 39 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42832237Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical Trial.JAMA Neurol2026https://conductscience.org/library/papers/42832237PubMed
42507235Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer's Disease.Curr Psychiatry Rep2026https://conductscience.org/library/papers/42507235PubMed
42426363Defining and Measuring Cognitive Decline and Clinical Relevance.Neurol Ther2026https://conductscience.org/library/papers/42426363PubMed
42348506Just Semantics? How Diagnostic Criteria Influence Physician-Patient Narratives in Alzheimer's Disease.Neurodegener Dis2026https://conductscience.org/library/papers/42348506PubMed
42254757Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE).Alzheimers Dement (N Y)2026https://conductscience.org/library/papers/42254757PubMed
41950013Expert consensus on communicating tau PET results to persons living with MCI or dementia: Findings from a modified Delphi study.Alzheimers Dement2026https://conductscience.org/library/papers/41950013PubMed
41929956Qualitative insights into participant and care partner perspectives on research-based Alzheimer's disease biomarker testing and disclosure.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/41929956PubMed
41639575Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias.Nature2026https://conductscience.org/library/papers/41639575PubMed
41623897Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/41623897PubMed
41550025Genetic and Pathological Testing Attitudes for Parkinson's Disease in At-Risk Relatives.Mov Disord Clin Pract2026https://conductscience.org/library/papers/41550025PubMed
41500647
What is the psychological and cognitive impact of returning Alzheimer disease dementia research results to healthy research participants? a delayed-start randomised clinical trial protocol for the WeSHARE study (Washington University study of having Alzheimer disease research results explained).
BMJ Open2026https://conductscience.org/library/papers/41500647PubMed
41390659Disclosure of onset-predictive biomarker results to research participants at risk of genetic frontotemporal dementia: a European perspective.Alzheimers Res Ther2025https://conductscience.org/library/papers/41390659PubMed
41366831Clinical definition, biological characterization, and detection guidelines of subjective cognitive decline due to Alzheimer's disease and related dementia: A position paper from ISTAART SCD PIA.Alzheimers Dement2025https://conductscience.org/library/papers/41366831PubMed
41113830Fair allocation of telemedical counseling services in early detection of Alzheimer's disease: Empirically informed ethical considerations.Alzheimers Dement (Amst)2025https://conductscience.org/library/papers/41113830PubMed
40997223Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.J Alzheimers Dis2025https://conductscience.org/library/papers/40997223PubMed
40636063It is time to share Alzheimer biomarker results in dementia with Lewy bodies.Alzheimers Dement (Amst)2025https://conductscience.org/library/papers/40636063PubMed
40545555Return of research results across the Alzheimer's Disease Research Centers network.Alzheimers Dement2025https://conductscience.org/library/papers/40545555PubMed
40527327Moving from dementia risk disclosure to return of individual research results: a bioethics perspective.Lancet Healthy Longev2025https://conductscience.org/library/papers/40527327PubMed
40368121Toward a person-centered return of research results of dementia risk: A pluralistic, constructive expansion.J Alzheimers Dis2025https://conductscience.org/library/papers/40368121PubMed
40327345Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease.JAMA Netw Open2025https://conductscience.org/library/papers/40327345PubMed

See all 46 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36720642

GET https://conductscience.org/api/papers/v1/36720642/references?page=2